Research

Flagship’s cTA™ Platform and Decision Support Process creates confidence in hypothesis for drug development strategies.

Target Validation & Hypothesis Generation

Make informed early pipeline decisions that will accelerate the right clinical path.

Flagship is the ideal partner when highly precise, objective tissue interpretation is needed for:

  • Confidently formulating the right tissue context questions, and
  • Making informed decisions with robust tissue data in order to determine the early clinical pathway.

Flagship helps you design and execute biomarker-driven clinical strategies by applying our expertise in:

  • Whole slide scoring
  • Automated cell type classification
  • Scientifically sound and efficient hypothesis testing

Flagship has created over 100 fit-for purpose assays and has provided valuable tissue data for over 400 projects

proven success

Flagship got staining just the way they wanted it, analyzed it, and developed metrics that helped us understand what we could not get from other laboratories.

-US Director of BioAnalytics for a global pharmaceutical company

SOLVE DIFFICULT TISSUE ANALYSIS CHALLENGES WITH OUR UNIQUE APPROACH

Work With Us

Breadth and depth in people and technology to deliver on any challenge
Work With Us